Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
2.
J Drugs Dermatol ; 18(7): 693-696, 2019 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-31334929

RESUMO

Keratoacathoma (KA) is a unique clinical pathological entity that is difficult to categorize. Differentiating a KA from a squamous cell carcinoma (SCC) is important for treatment implications but is often challenging. We report a patient with a solitary KA of the skin of the right ala successfully treated with intralesional (IL) injections of methotrexate (MTX). We also provide a review of the literature on IL-MTX as a treatment modality for KA. J Drugs Dermatol. 2019;18(7):693-696.


Assuntos
Antineoplásicos/administração & dosagem , Carcinoma de Células Escamosas/terapia , Ceratoacantoma/terapia , Metotrexato/administração & dosagem , Neoplasias Nasais/terapia , Neoplasias Cutâneas/terapia , Biópsia , Bleomicina/administração & dosagem , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/patologia , Feminino , Fluoruracila/administração & dosagem , Humanos , Injeções Intralesionais , Ceratoacantoma/diagnóstico , Ceratoacantoma/patologia , Pessoa de Meia-Idade , Cirurgia de Mohs , Neoplasias Nasais/diagnóstico , Neoplasias Nasais/patologia , Pele/efeitos dos fármacos , Pele/patologia , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/patologia , Resultado do Tratamento
3.
J Drugs Dermatol ; 18(6): 587-591, 2019 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-31251553

RESUMO

With the rising popularity of fillers for facial rejuvenation coupled with the paucity of regulations on credentialing of qualified injectors, the number of filler related complications is increasing. Although the majority of complications are mild, vascular occlusion is the most feared and dangerous. Minimizing risk of vascular complications through a comprehensive understanding of vascular anatomy and careful technique is important. Physicians who perform filler injections should also be able to promptly recognize complications and manage them. We report a case of vascular occlusion successfully managed using high dose hyaluronidase and provide a review of the literature including incidence, management, and techniques to prevent vascular complications. J Drugs Dermatol. 2019;18(6):587-591.


Assuntos
Arteriopatias Oclusivas/induzido quimicamente , Técnicas Cosméticas/efeitos adversos , Preenchedores Dérmicos/efeitos adversos , Ácido Hialurônico/efeitos adversos , Hialuronoglucosaminidase/administração & dosagem , Adulto , Arteriopatias Oclusivas/tratamento farmacológico , Arteriopatias Oclusivas/prevenção & controle , Preenchedores Dérmicos/administração & dosagem , Face/irrigação sanguínea , Feminino , Humanos , Ácido Hialurônico/administração & dosagem , Injeções Intralesionais , Injeções Subcutâneas , Necrose/induzido quimicamente , Necrose/tratamento farmacológico , Necrose/prevenção & controle , Rejuvenescimento , Pele/irrigação sanguínea , Pele/efeitos dos fármacos , Pele/patologia , Resultado do Tratamento
4.
J Drugs Dermatol ; 17(11): 1157 - 1162, 2018 11 01.
Artigo em Inglês | MEDLINE | ID: mdl-30481953

RESUMO

OBJECTIVE: The aim of this study was to evaluate the incidence of adverse effects following laser skin resurfacing with the microablative carbon dioxide (CO2) laser system (SmartXide DOT; DEKA, Calenzano, Italy). METHODS: A retrospective chart review was performed. Data was collected for DOT laser procedures performed at three clinical centers from 2008-2014. Results: Of the 1,081 DOT laser procedures, there were 13 complications (1.3% of all cases), which included eleven cases of prolonged erythema and two cases of post-inflammatory hyperpigmentation. Of note, there were no cases of scarring. LIMITATIONS: This was a retrospective chart review. Data was collected from laser case logs. However, all patients with complications were evaluated clinically by a physician. CONCLUSION: Microablative fractional resurfacing with the DOT laser enables treatment of a diversity of skin conditions with short post-procedure recovery time and an extremely low incidence of adverse side effects. J Drugs Dermatol. 2018;17(11):1157-1162.


Assuntos
Dermatoses Faciais/cirurgia , Lasers de Gás/efeitos adversos , Envelhecimento da Pele , Idoso de 80 Anos ou mais , Eritema/etiologia , Feminino , Humanos , Incidência , Indiana , Pescoço , Cidade de Nova Iorque , Complicações Pós-Operatórias/etiologia , Estudos Retrospectivos , Ritidoplastia/instrumentação
8.
Dermatol Clin ; 37(4): 435-441, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31466584

RESUMO

Although surgical intervention remains the standard of care for nonmelanoma skin cancer, other treatment modalities have been studied and used. Nonsurgical treatment methods include cryotherapy, topical medications, photodynamic therapy, radiation therapy, Hedgehog pathway inhibitors, programmed cell death protein 1 inhibitors, and active nonintervention. Despite the favorable efficacy of surgical treatment methods, many factors, including but not limited to patient age, preference, and severity of disease, must be taken into consideration when choosing the most appropriate, patient-centered treatment approach.


Assuntos
Antineoplásicos/uso terapêutico , Carcinoma Basocelular/terapia , Carcinoma de Células Escamosas/terapia , Fotoquimioterapia , Radioterapia , Neoplasias Cutâneas/terapia , Administração Cutânea , Anilidas/uso terapêutico , Antineoplásicos Imunológicos/uso terapêutico , Compostos de Bifenilo/uso terapêutico , Criocirurgia , Inibidores de Ciclo-Oxigenase/uso terapêutico , Diclofenaco/uso terapêutico , Diterpenos/uso terapêutico , Fluoruracila/uso terapêutico , Humanos , Imiquimode/uso terapêutico , Receptor de Morte Celular Programada 1/antagonistas & inibidores , Piridinas/uso terapêutico , Conduta Expectante
10.
J Dermatolog Treat ; 27(1): 91-4, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26208163

RESUMO

BACKGROUND: Cryosurgery is a common treatment modality for many dermatological conditions; however, the extent to which it is used and by which medical specialties is not well characterized. OBJECTIVE: To determine the rates of cryosurgery use over time, the top dermatoses treated by cryosurgery, patient demographics and the rate at which practitioners used cryosurgery. METHODS: We used the National Ambulatory Medical Care Survey (NAMCS) from 1993 to 2010 in order to quantify the use of cryosurgery in outpatient offices. For visits where cryosurgery was utilized, the leading diagnoses, treating physician specialties, and patient ages were tabulated. RESULTS: Cryosurgery was most commonly used for treating actinic keratoses (48% of visits), seborrheic keratoses (25% of visits) and verrucae (21% of visits). Dermatologists performed 82% of all cryosurgeries, followed by family/internal medicine physicians (13.6%) and pediatricians (2.8%). The use of cryosurgery for these dermatoses has increased over time (p < 0.0001), especially in patients over the age of 65 years. Physicians in offices with health maintenance organization-based practices were more likely to utilize cryosurgery. LIMITATIONS: Since NAMCS data are cross-sectional, we are unable to determine whether patients tried and failed other treatments. CONCLUSIONS: As the baby boomer generation ages, the demand for cryosurgery will likely further increase.


Assuntos
Criocirurgia/estatística & dados numéricos , Ceratose Actínica/cirurgia , Dermatopatias/cirurgia , Adolescente , Adulto , Idoso , Estudos Transversais , Pesquisas sobre Atenção à Saúde , Humanos , Pessoa de Meia-Idade , Estados Unidos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA